Enrolling

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

I4V-MC-JAIO -

The main purpose of the study is to assess efficacy and safety of Baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age.

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
6 - 17 years
Conditions the trial is for
Alopecia Areata (hair loss)
What the trial is testing?
baricitinib
Could I receive a Placebo?
Yes
Enrollment Goal
595
Trial Dates
Feb 27, 2023 - Aug 2029
How long will I be in the trial?
The study will last approximately 2.5 years long and up to 18 visits.
Trial Phase
III

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have severe areata alopecia (AA) for at least 1 year

  • Current AA episode of at least 6 months’ duration with hair loss encompassing ≥50% of the scalp

  • Current episode of severe to very severe alopecia areata of less than 8 years 

  • Participants who have severe AA for ≥8 years may be enrolled if episodes of regrowth, spontaneous or under treatment, have been observed on the affected areas over the past 8 years

Participants Must Not:

  • Participants must not have primarily “diffuse” type of alopecia areata

  • Participants must not be currently experiencing other forms of alopecia or any other health problem that would make it difficult to see how the study drug is working on alopecia areata

  • Participants must not have topical applied to scalp within 4 weeks of randomization

Lilly Trial Alerts

Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.

Clinical Trial Resources